HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ferdinando Mannello Selected Research

Therapeutics

4/2024Transcriptional signatures in human macrophage-like cells infected by Leishmania infantum, Leishmania major and Leishmania tropica.
3/2022Do Circulating Histones Represent the Missing Link among COVID-19 Infection and Multiorgan Injuries, Microvascular Coagulopathy and Systemic Hyperinflammation?
4/2021Reasoned therapeutic protocol in outpatients with COVID-19.
12/2020Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment.
11/2020Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases.
10/2016Chronic venous disease - Part I: Inflammatory biomarkers in wound healing.
10/2016Chronic venous disease - Part II: Proteolytic biomarkers in wound healing.
1/2016Pharmacologic treatment to improve venous leg ulcer healing.
5/2009Statins and breast cancer: may matrix metalloproteinase be the missing link.
1/2006Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ferdinando Mannello Research Topics

Disease

21Breast Neoplasms (Breast Cancer)
01/2017 - 05/2007
18Neoplasms (Cancer)
01/2017 - 01/2006
7Inflammation (Inflammations)
09/2023 - 11/2009
6COVID-19
09/2023 - 04/2021
5Sepsis (Septicemia)
09/2023 - 01/2022
5Wounds and Injuries (Trauma)
04/2023 - 10/2016
5Infections
03/2023 - 11/2009
4Breast Cyst
06/2014 - 05/2006
3Atherosclerosis
09/2021 - 12/2018
3Venous Insufficiency
12/2020 - 10/2017
3Chronic Disease (Chronic Diseases)
11/2020 - 05/2013
3Leg Ulcer
10/2016 - 07/2014
3Fibrocystic Breast Disease (Chronic Cystic Mastitis)
06/2014 - 05/2006
3Leukemia
05/2013 - 03/2006
2Hypoxia (Hypoxemia)
07/2023 - 01/2011
2Thrombosis (Thrombus)
01/2022 - 01/2022
2Thromboangiitis Obliterans (Buerger's Disease)
09/2021 - 04/2020
2Prostatic Neoplasms (Prostate Cancer)
05/2017 - 10/2008
2Cysts
04/2015 - 06/2014
2Vascular Diseases (Vascular Disease)
12/2013 - 05/2013
2Varicose Veins (Varicose Vein)
05/2013 - 02/2011
2Neoplasm Metastasis (Metastasis)
11/2009 - 01/2006
2Carcinogenesis
09/2008 - 05/2007
1Leishmaniasis
04/2024
1Thrombocytopenia (Thrombopenia)
11/2023
1Thromboinflammation
09/2023
1Cytokine Release Syndrome
01/2023
1Stroke (Strokes)
03/2022
1Myocardial Infarction
03/2022
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
09/2021
1Vasculitis (Vasculitides)
09/2021
1Ulcer
12/2020
1Chronic Kidney Failure (Chronic Renal Failure)
11/2020
1Diabetes Mellitus
11/2020
1Hemoglobinopathies
11/2020
1Metabolic Diseases (Metabolic Disease)
11/2020
1Type 2 Diabetes Mellitus (MODY)
03/2020
1Hypoglycemia (Reactive Hypoglycemia)
03/2020
1Body Weight (Weight, Body)
03/2020
1Multiple Sclerosis
01/2018
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2018
1Hyperplasia
05/2017
1Pain (Aches)
10/2016

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
09/2023 - 08/2008
15Matrix Metalloproteinases (MMPs)IBA
04/2023 - 01/2003
8Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2006
6Histones (Histone)IBA
11/2023 - 01/2022
5glucuronyl glucosamine glycan sulfate (sulodexide)IBA
10/2017 - 05/2013
5GlycosaminoglycansIBA
10/2017 - 02/2011
4LipidsIBA
09/2021 - 05/2006
4CytokinesIBA
12/2020 - 11/2009
4EnzymesIBA
05/2013 - 05/2006
3AntioxidantsIBA
07/2023 - 04/2020
3CollagenIBA
12/2020 - 02/2011
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015 - 05/2006
3AluminumIBA
11/2013 - 01/2009
3ProstaglandinsIBA
10/2008 - 05/2007
2oxidized low density lipoproteinIBA
09/2021 - 12/2018
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2020 - 10/2017
2ChemokinesIBA
12/2020 - 01/2014
2AlbuminsIBA
12/2020 - 11/2020
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2020 - 10/2008
2Glucose (Dextrose)FDA LinkGeneric
11/2020 - 03/2020
2Metalloproteases (Metalloproteinases)IBA
12/2018 - 01/2014
2Peptide Hydrolases (Proteases)FDA Link
05/2017 - 01/2006
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
06/2014 - 12/2011
2Plasminogen Activator Inhibitor 1IBA
07/2013 - 10/2008
2GelatinasesIBA
05/2013 - 07/2007
2IronIBA
04/2011 - 10/2010
2Ferritins (Ferritin)IBA
04/2011 - 10/2010
2Arachidonic Acid (Vitamin F)IBA
09/2008 - 05/2007
2ErythropoietinFDA Link
07/2008 - 01/2008
1Indicators and Reagents (Reagents)IBA
09/2023
1Sodium Hypochlorite (Clorox)IBA
04/2023
1SolutionsIBA
04/2023
1Heparinoids (Heparinoid)IBA
01/2022
1LipopolysaccharidesIBA
01/2022
1fibrin fragment D (D-dimer)IBA
09/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2021
1AutoantibodiesIBA
09/2021
1Troleandomycin (TAO)FDA Link
09/2021
1CreatinineIBA
09/2021
1Protein CIBA
09/2021
1Pancreatic Elastase (Elastase)IBA
12/2020
1Plasminogen Activators (Plasminogen Activator)IBA
12/2020
1FibrinIBA
12/2020
1Hemoglobins (Hemoglobin)IBA
11/2020
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2020
1Dipeptidyl-Peptidase IV InhibitorsIBA
03/2020
1Glucagon-Like Peptide 1 (GLP 1)IBA
03/2020
1Sodium-Glucose Transport ProteinsIBA
03/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2020
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
03/2020
1Oligoclonal BandsIBA
01/2018
1Protein Isoforms (Isoforms)IBA
10/2017
1EndoglinIBA
10/2017

Therapy/Procedure

10Therapeutics
04/2024 - 01/2006
1Operative Surgical Procedures
12/2020
1Lasers (Laser)
05/2017
1Precision Medicine
01/2017